SCHEMBL22326777

SCHEMBL22326777

CCc1cnc2c(=O)[nH]cnn12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
ADORA2A P29274 5/20 0.33
PDE4A P27815 4/20 0.33
PDE4B Q07343 4/20 0.33
PDE4C Q08493 4/20 0.33
PDE4D Q08499 4/20 0.33
ADORA1 P30542 2/20 0.33
CYP1A2 P05177 1/20 0.33
TMIGD3 P0DMS9 1/20 0.33
CYP2C9 P11712 1/20 0.33
MAPT P10636 1/20 0.33
ADORA2B P29275 3/20 0.32
ADORA3 P0DMS8 1/20 0.32
HPGD P15428 1/20 0.32
BLM P54132 1/20 0.32
PDE3A Q14432 1/20 0.32
HSD17B10 Q99714 1/20 0.32
NR1H2 P55055 1/20 0.32
HTT P42858 1/20 0.31
MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24499701 0.80 ALDH1A1 (0.37) ALDH1A1MAPTMEN1KMT2A
SCHEMBL18520816 0.77 ALDH1A1 (0.42) ALDH1A1ADORA2AMAPTHPGDBLM
SCHEMBL22547338 0.74 ALDH1A1 (0.39) ALDH1A1ADORA2AMAPTHPGDBLM
SCHEMBL22349704 0.73 ALDH1A1 (0.39) ALDH1A1MAPTHPGDHTT
SCHEMBL22349659 0.72 ALDH1A1 (0.33) ALDH1A1ADORA2APDE4APDE4BPDE4C
SCHEMBL22399904 0.71 ALDH1A1 (0.37) ALDH1A1CYP1A2MAPTMEN1KMT2A
SCHEMBL22797271 0.70 PDE4A (0.33) ALDH1A1ADORA2APDE4APDE4BPDE4C
SCHEMBL22399282 0.69 ALDH1A1 (0.36) ALDH1A1CYP1A2
SCHEMBL22797115 0.68 KDM6B (0.34) ALDH1A1ADORA2APDE4APDE4BPDE4C
SCHEMBL13201566 0.67 ALDH1A1 (0.39) ALDH1A1HPGDHSD17B10NR1H2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738074-B2 Cyclic di-nucleotide compounds as STING agonists MERCK SHARP & DOHME CORP. (US) 2020-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738074-B2 Cyclic di-nucleotide compounds as STING agonists STING1, CGAS, IFNAR1 ALDH1A1 4323/4885ADORA2A 72/4885PDE4A 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.